

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.87030368 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.87030368 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 5.87030368 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.87030368 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 5.87030368 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.87030368 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.42958977 |
| 8 | negative regulation of cell killing (GO:0031342) | 5.42958977 |
| 9 | detection of molecule of bacterial origin (GO:0032490) | 5.35401166 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.29379557 |
| 11 | macrophage activation involved in immune response (GO:0002281) | 5.10550979 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.90628265 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 4.85984236 |
| 14 | response to peptidoglycan (GO:0032494) | 4.84348780 |
| 15 | detection of other organism (GO:0098543) | 4.81819028 |
| 16 | locomotory exploration behavior (GO:0035641) | 4.69812758 |
| 17 | lymph vessel development (GO:0001945) | 4.66354496 |
| 18 | detection of external biotic stimulus (GO:0098581) | 4.62758963 |
| 19 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.51646920 |
| 20 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.46454248 |
| 21 | cellular extravasation (GO:0045123) | 4.41237298 |
| 22 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.40314951 |
| 23 | negative regulation of interleukin-12 production (GO:0032695) | 4.39267189 |
| 24 | detection of bacterium (GO:0016045) | 4.36723482 |
| 25 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.23219972 |
| 26 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.06554374 |
| 27 | detection of biotic stimulus (GO:0009595) | 4.03945572 |
| 28 | microglial cell activation (GO:0001774) | 3.94907096 |
| 29 | macrophage activation (GO:0042116) | 3.92827828 |
| 30 | response to host immune response (GO:0052572) | 3.91727956 |
| 31 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.91727956 |
| 32 | neutrophil activation (GO:0042119) | 3.85885801 |
| 33 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.81821295 |
| 34 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.77946549 |
| 35 | response to host (GO:0075136) | 3.73216325 |
| 36 | response to host defenses (GO:0052200) | 3.73216325 |
| 37 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.73216325 |
| 38 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.73205464 |
| 39 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.70019624 |
| 40 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.68540062 |
| 41 | respiratory burst (GO:0045730) | 3.68053134 |
| 42 | synaptic vesicle maturation (GO:0016188) | 3.66408092 |
| 43 | granulocyte activation (GO:0036230) | 3.64740467 |
| 44 | regulation of synapse structural plasticity (GO:0051823) | 3.62706167 |
| 45 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.57145956 |
| 46 | leukocyte aggregation (GO:0070486) | 3.56834548 |
| 47 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.55561277 |
| 48 | neutrophil mediated immunity (GO:0002446) | 3.54884041 |
| 49 | regulation of gamma-delta T cell activation (GO:0046643) | 3.52975253 |
| 50 | regulation of mast cell degranulation (GO:0043304) | 3.50057208 |
| 51 | exploration behavior (GO:0035640) | 3.43751161 |
| 52 | myeloid cell activation involved in immune response (GO:0002275) | 3.43735322 |
| 53 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.43019121 |
| 54 | immunoglobulin mediated immune response (GO:0016064) | 3.41796197 |
| 55 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.39715469 |
| 56 | germinal center formation (GO:0002467) | 3.38091178 |
| 57 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.37745344 |
| 58 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.37352187 |
| 59 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.35917237 |
| 60 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.35517232 |
| 61 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.35147671 |
| 62 | positive regulation of mast cell activation (GO:0033005) | 3.29858012 |
| 63 | regulation of leukocyte degranulation (GO:0043300) | 3.29177410 |
| 64 | layer formation in cerebral cortex (GO:0021819) | 3.27736667 |
| 65 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.25632257 |
| 66 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.25608783 |
| 67 | response to interleukin-15 (GO:0070672) | 3.22553244 |
| 68 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.22039399 |
| 69 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.21363891 |
| 70 | response to muramyl dipeptide (GO:0032495) | 3.21228815 |
| 71 | vocalization behavior (GO:0071625) | 3.19104827 |
| 72 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.14841484 |
| 73 | gamma-aminobutyric acid transport (GO:0015812) | 3.07672654 |
| 74 | activation of protein kinase A activity (GO:0034199) | 3.06351595 |
| 75 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.06081318 |
| 76 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.04977384 |
| 77 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.04650650 |
| 78 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.04101032 |
| 79 | cellular response to type I interferon (GO:0071357) | 3.03969164 |
| 80 | type I interferon signaling pathway (GO:0060337) | 3.03969164 |
| 81 | response to type I interferon (GO:0034340) | 3.01622504 |
| 82 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.01372262 |
| 83 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.00015950 |
| 84 | regulation of mast cell activation (GO:0033003) | 2.99269366 |
| 85 | regulation of Rap GTPase activity (GO:0032317) | 2.99266071 |
| 86 | sodium ion export (GO:0071436) | 2.97973968 |
| 87 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.97810574 |
| 88 | negative regulation of T cell mediated immunity (GO:0002710) | 2.97764779 |
| 89 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.97353373 |
| 90 | endothelial cell chemotaxis (GO:0035767) | 2.94654215 |
| 91 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.93958716 |
| 92 | defense response to protozoan (GO:0042832) | 2.93737592 |
| 93 | myeloid leukocyte mediated immunity (GO:0002444) | 2.93563455 |
| 94 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.92462196 |
| 95 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.92362767 |
| 96 | positive regulation of interferon-alpha production (GO:0032727) | 2.92241010 |
| 97 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.91970927 |
| 98 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.91515578 |
| 99 | regulation of T cell tolerance induction (GO:0002664) | 2.87355379 |
| 100 | positive regulation of mast cell degranulation (GO:0043306) | 2.86748481 |
| 101 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.86748481 |
| 102 | dendritic spine morphogenesis (GO:0060997) | 2.85594963 |
| 103 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.85012827 |
| 104 | regulation of tolerance induction (GO:0002643) | 2.84951180 |
| 105 | regulation of regulated secretory pathway (GO:1903305) | 2.84604146 |
| 106 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.84042930 |
| 107 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.83811393 |
| 108 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.83373831 |
| 109 | cellular potassium ion homeostasis (GO:0030007) | 2.82949013 |
| 110 | myeloid leukocyte activation (GO:0002274) | 2.82193467 |
| 111 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.81490510 |
| 112 | T-helper 1 type immune response (GO:0042088) | 2.81194400 |
| 113 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.81055937 |
| 114 | regulation of interferon-alpha production (GO:0032647) | 2.78674178 |
| 115 | synaptic vesicle exocytosis (GO:0016079) | 2.77414582 |
| 116 | neutrophil chemotaxis (GO:0030593) | 2.76962653 |
| 117 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.76912309 |
| 118 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.76443366 |
| 119 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.76286930 |
| 120 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.76263116 |
| 121 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.76146126 |
| 122 | adenosine receptor signaling pathway (GO:0001973) | 2.76143857 |
| 123 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.76010247 |
| 124 | negative regulation of dendrite development (GO:2000171) | 2.75517751 |
| 125 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.74512273 |
| 126 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.74328270 |
| 127 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.74320865 |
| 128 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.72835458 |
| 129 | positive regulation of leukocyte degranulation (GO:0043302) | 2.72004427 |
| 130 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.71372429 |
| 131 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.70641259 |
| 132 | proline transport (GO:0015824) | 2.70224335 |
| 133 | dendritic cell migration (GO:0036336) | 2.69394877 |
| 134 | neutrophil migration (GO:1990266) | 2.69392178 |
| 135 | negative regulation of type 2 immune response (GO:0002829) | 2.68296201 |
| 136 | cellular response to interleukin-15 (GO:0071350) | 2.66955247 |
| 137 | negative regulation of vascular permeability (GO:0043116) | 2.66805232 |
| 138 | dendritic cell chemotaxis (GO:0002407) | 2.66022750 |
| 139 | regulation of synaptic plasticity (GO:0048167) | 2.65632215 |
| 140 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.65373246 |
| 141 | response to protozoan (GO:0001562) | 2.63792120 |
| 142 | regulation of dendritic spine development (GO:0060998) | 2.63161196 |
| 143 | potassium ion import (GO:0010107) | 2.61856294 |
| 144 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.61180593 |
| 145 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.60919391 |
| 146 | regulation of macrophage cytokine production (GO:0010935) | 2.60161094 |
| 147 | glutamate receptor signaling pathway (GO:0007215) | 2.59392035 |
| 148 | cAMP biosynthetic process (GO:0006171) | 2.59249986 |
| 149 | positive regulation of synapse maturation (GO:0090129) | 2.58739856 |
| 150 | neurotransmitter secretion (GO:0007269) | 2.56284799 |
| 151 | glutamate secretion (GO:0014047) | 2.55675153 |
| 152 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.55613114 |
| 153 | long-term synaptic potentiation (GO:0060291) | 2.54744028 |
| 154 | positive regulation of fibroblast migration (GO:0010763) | 2.54633710 |
| 155 | dopamine receptor signaling pathway (GO:0007212) | 2.53369438 |
| 156 | membrane depolarization during action potential (GO:0086010) | 2.53229572 |
| 157 | positive regulation of Rap GTPase activity (GO:0032854) | 2.53153585 |
| 158 | positive regulation of vesicle fusion (GO:0031340) | 2.51271346 |
| 159 | neuromuscular process controlling balance (GO:0050885) | 2.50461646 |
| 160 | long term synaptic depression (GO:0060292) | 2.50122672 |
| 161 | protein localization to synapse (GO:0035418) | 2.48090646 |
| 162 | regulation of synaptic vesicle transport (GO:1902803) | 2.47780657 |
| 163 | neuronal action potential propagation (GO:0019227) | 2.46223742 |
| 164 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.45395035 |
| 165 | regulation of postsynaptic membrane potential (GO:0060078) | 2.45270536 |
| 166 | cellular sodium ion homeostasis (GO:0006883) | 2.44854442 |
| 167 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.43355932 |
| 168 | long-term memory (GO:0007616) | 2.42779583 |
| 169 | behavioral fear response (GO:0001662) | 2.40782443 |
| 170 | behavioral defense response (GO:0002209) | 2.40782443 |
| 171 | cell communication involved in cardiac conduction (GO:0086065) | 2.39085368 |
| 172 | synaptic transmission, glutamatergic (GO:0035249) | 2.38816986 |
| 173 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.35894047 |
| 174 | axonal fasciculation (GO:0007413) | 2.34605053 |
| 175 | membrane depolarization (GO:0051899) | 2.34550206 |
| 176 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.34349792 |
| 177 | prepulse inhibition (GO:0060134) | 2.34029234 |
| 178 | B cell receptor signaling pathway (GO:0050853) | 2.30816981 |
| 179 | response to amphetamine (GO:0001975) | 2.30427153 |
| 180 | establishment of nucleus localization (GO:0040023) | 2.30212637 |
| 181 | neuron-neuron synaptic transmission (GO:0007270) | 2.29644657 |
| 182 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.29630633 |
| 183 | dendritic spine organization (GO:0097061) | 2.29166598 |
| 184 | regulation of ARF GTPase activity (GO:0032312) | 2.28759554 |
| 185 | cAMP metabolic process (GO:0046058) | 2.26087238 |
| 186 | regulation of ARF protein signal transduction (GO:0032012) | 2.25741035 |
| 187 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.25443823 |
| 188 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.24740228 |
| 189 | neuron recognition (GO:0008038) | 2.24095700 |
| 190 | cell communication by electrical coupling (GO:0010644) | 2.23890260 |
| 191 | regulation of protein kinase A signaling (GO:0010738) | 2.23052768 |
| 192 | auditory behavior (GO:0031223) | 2.22295369 |
| 193 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.21014965 |
| 194 | innervation (GO:0060384) | 2.20067357 |
| 195 | vesicle transport along microtubule (GO:0047496) | 2.18658342 |
| 196 | stress fiber assembly (GO:0043149) | 2.18195703 |
| 197 | cAMP catabolic process (GO:0006198) | 2.17517252 |
| 198 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.16980871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.60192623 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.37297006 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.82401459 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.69349349 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.32065177 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.20587423 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.15953280 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.96365328 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.92134350 |
| 10 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.70184875 |
| 11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.67395751 |
| 12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.66443057 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.62300298 |
| 14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.62300298 |
| 15 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.59969814 |
| 16 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.45866258 |
| 17 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.44604522 |
| 18 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.43104303 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.39536606 |
| 20 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.37794488 |
| 21 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.37625762 |
| 22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.30880998 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.30500936 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.26291064 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.21327310 |
| 26 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.18524930 |
| 27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.16587065 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.15621808 |
| 29 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.13945240 |
| 30 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.12238532 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.12072901 |
| 32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.07797016 |
| 33 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.02789939 |
| 34 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.00677155 |
| 35 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.96163813 |
| 36 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.95751792 |
| 37 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.94807362 |
| 38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94781216 |
| 39 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.93893284 |
| 40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.93407306 |
| 41 | MAF_26560356_Chip-Seq_TH1_Human | 1.90409163 |
| 42 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.87738481 |
| 43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.86849507 |
| 44 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.86437762 |
| 45 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.86345880 |
| 46 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.85650876 |
| 47 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.83715316 |
| 48 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.81490581 |
| 49 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.77798981 |
| 50 | MYC_22102868_ChIP-Seq_BL_Human | 1.77283103 |
| 51 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.75885905 |
| 52 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.69889581 |
| 53 | MYB_26560356_Chip-Seq_TH2_Human | 1.64025476 |
| 54 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.63637110 |
| 55 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.62222900 |
| 56 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.61654895 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.58426550 |
| 58 | UTX_26944678_Chip-Seq_JUKART_Human | 1.57751639 |
| 59 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.53894699 |
| 60 | KDM2B_26808549_Chip-Seq_K562_Human | 1.53590851 |
| 61 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.53305261 |
| 62 | MYB_26560356_Chip-Seq_TH1_Human | 1.50839303 |
| 63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.49759304 |
| 64 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.47758181 |
| 65 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.46132743 |
| 66 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.45440651 |
| 67 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44738753 |
| 68 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.42212476 |
| 69 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.42106615 |
| 70 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.41824171 |
| 71 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.41744055 |
| 72 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.41644914 |
| 73 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.37425669 |
| 74 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.36426663 |
| 75 | RXR_22108803_ChIP-Seq_LS180_Human | 1.36145800 |
| 76 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.35755319 |
| 77 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.33227644 |
| 78 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32406549 |
| 79 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31125705 |
| 80 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.27794347 |
| 81 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27284947 |
| 82 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.27249157 |
| 83 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.26003158 |
| 84 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.25727605 |
| 85 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.24946761 |
| 86 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.24691002 |
| 87 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.24690213 |
| 88 | MAF_26560356_Chip-Seq_TH2_Human | 1.24682591 |
| 89 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24485860 |
| 90 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.23900365 |
| 91 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22774298 |
| 92 | TP53_16413492_ChIP-PET_HCT116_Human | 1.22434187 |
| 93 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22103735 |
| 94 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.21727852 |
| 95 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.20451206 |
| 96 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.20273985 |
| 97 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.19090353 |
| 98 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17901093 |
| 99 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16617802 |
| 100 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.16549823 |
| 101 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16418141 |
| 102 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16371453 |
| 103 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.15959729 |
| 104 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.15753202 |
| 105 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.15097081 |
| 106 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15052814 |
| 107 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14364704 |
| 108 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.14121071 |
| 109 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.13553365 |
| 110 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13384163 |
| 111 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.12858867 |
| 112 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.12253091 |
| 113 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.11959791 |
| 114 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.11348084 |
| 115 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10231516 |
| 116 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.09291546 |
| 117 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08642603 |
| 118 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.08609526 |
| 119 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.08218510 |
| 120 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.07285132 |
| 121 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.06245259 |
| 122 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.05800560 |
| 123 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05661309 |
| 124 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05602161 |
| 125 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.04002648 |
| 126 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03561035 |
| 127 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03381629 |
| 128 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.03192908 |
| 129 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.03134473 |
| 130 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.03055276 |
| 131 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02076957 |
| 132 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.01920848 |
| 133 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.01786949 |
| 134 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01341278 |
| 135 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.00082803 |
| 136 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00046823 |
| 137 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.99882371 |
| 138 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99616207 |
| 139 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98794036 |
| 140 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.98443964 |
| 141 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98170601 |
| 142 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.98100478 |
| 143 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.97283828 |
| 144 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97195970 |
| 145 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96933416 |
| 146 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.96655951 |
| 147 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.95505952 |
| 148 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.95345899 |
| 149 | AR_19668381_ChIP-Seq_PC3_Human | 0.95324203 |
| 150 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.95231415 |
| 151 | GATA1_19941826_ChIP-Seq_K562_Human | 0.94181486 |
| 152 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.93676432 |
| 153 | AR_25329375_ChIP-Seq_VCAP_Human | 0.93237732 |
| 154 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.93137837 |
| 155 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.93043108 |
| 156 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.92803832 |
| 157 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92535636 |
| 158 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.91189585 |
| 159 | GATA1_22025678_ChIP-Seq_K562_Human | 0.90202060 |
| 160 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90190809 |
| 161 | SPI1_23127762_ChIP-Seq_K562_Human | 0.89285074 |
| 162 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.89277331 |
| 163 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.88923475 |
| 164 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.88803866 |
| 165 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.88512097 |
| 166 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.87158103 |
| 167 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.86806512 |
| 168 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.86659131 |
| 169 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.85476792 |
| 170 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.85461343 |
| 171 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84206984 |
| 172 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84081185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.61562935 |
| 2 | MP0003436_decreased_susceptibility_to | 4.03638831 |
| 3 | MP0002822_catalepsy | 3.59529304 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.25103699 |
| 5 | MP0010368_abnormal_lymphatic_system | 3.17153045 |
| 6 | MP0003191_abnormal_cellular_cholesterol | 3.11013128 |
| 7 | MP0001968_abnormal_touch/_nociception | 3.08128564 |
| 8 | MP0001879_abnormal_lymphatic_vessel | 3.02484855 |
| 9 | MP0002419_abnormal_innate_immunity | 2.98967077 |
| 10 | MP0003880_abnormal_central_pattern | 2.94976664 |
| 11 | MP0004270_analgesia | 2.79767462 |
| 12 | MP0009785_altered_susceptibility_to | 2.68054014 |
| 13 | MP0006082_CNS_inflammation | 2.62126417 |
| 14 | MP0005025_abnormal_response_to | 2.60272877 |
| 15 | MP0008260_abnormal_autophagy | 2.54898199 |
| 16 | MP0002063_abnormal_learning/memory/cond | 2.47676329 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.44555914 |
| 18 | MP0005167_abnormal_blood-brain_barrier | 2.41709103 |
| 19 | MP0005451_abnormal_body_composition | 2.41426946 |
| 20 | MP0009745_abnormal_behavioral_response | 2.40347642 |
| 21 | MP0002735_abnormal_chemical_nociception | 2.33859595 |
| 22 | MP0003172_abnormal_lysosome_physiology | 2.32523760 |
| 23 | MP0002736_abnormal_nociception_after | 2.26790340 |
| 24 | MP0001533_abnormal_skeleton_physiology | 2.22210500 |
| 25 | MP0005671_abnormal_response_to | 2.21910392 |
| 26 | MP0002909_abnormal_adrenal_gland | 2.21690973 |
| 27 | MP0002723_abnormal_immune_serum | 2.21460193 |
| 28 | MP0002452_abnormal_antigen_presenting | 2.20454167 |
| 29 | MP0004272_abnormal_basement_membrane | 2.20446914 |
| 30 | MP0004858_abnormal_nervous_system | 2.19362071 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 2.17436884 |
| 32 | MP0010234_abnormal_vibrissa_follicle | 2.13737738 |
| 33 | MP0002420_abnormal_adaptive_immunity | 2.09097638 |
| 34 | MP0001819_abnormal_immune_cell | 2.07324241 |
| 35 | MP0003303_peritoneal_inflammation | 2.04540884 |
| 36 | MP0005058_abnormal_lysosome_morphology | 2.02272965 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.97291200 |
| 38 | MP0004510_myositis | 1.82828182 |
| 39 | MP0002405_respiratory_system_inflammati | 1.81534705 |
| 40 | MP0008961_abnormal_basal_metabolism | 1.80475092 |
| 41 | MP0004947_skin_inflammation | 1.78595553 |
| 42 | MP0003183_abnormal_peptide_metabolism | 1.76621403 |
| 43 | MP0002132_abnormal_respiratory_system | 1.73906264 |
| 44 | MP0002572_abnormal_emotion/affect_behav | 1.72763321 |
| 45 | MP0002064_seizures | 1.71952423 |
| 46 | MP0008874_decreased_physiological_sensi | 1.68497591 |
| 47 | MP0003828_pulmonary_edema | 1.68445071 |
| 48 | MP0000013_abnormal_adipose_tissue | 1.65023841 |
| 49 | MP0005423_abnormal_somatic_nervous | 1.63937520 |
| 50 | MP0000858_altered_metastatic_potential | 1.63076059 |
| 51 | MP0002733_abnormal_thermal_nociception | 1.61672006 |
| 52 | MP0001845_abnormal_inflammatory_respons | 1.61324808 |
| 53 | MP0001501_abnormal_sleep_pattern | 1.58879916 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.55757155 |
| 55 | MP0003690_abnormal_glial_cell | 1.54215640 |
| 56 | MP0001486_abnormal_startle_reflex | 1.53595781 |
| 57 | MP0003075_altered_response_to | 1.52303163 |
| 58 | * MP0000716_abnormal_immune_system | 1.51101259 |
| 59 | MP0002998_abnormal_bone_remodeling | 1.50149169 |
| 60 | MP0009764_decreased_sensitivity_to | 1.49864782 |
| 61 | MP0002398_abnormal_bone_marrow | 1.44082995 |
| 62 | MP0008569_lethality_at_weaning | 1.42878294 |
| 63 | MP0009780_abnormal_chondrocyte_physiolo | 1.42786886 |
| 64 | MP0008469_abnormal_protein_level | 1.40547449 |
| 65 | MP0005409_darkened_coat_color | 1.40191507 |
| 66 | MP0003763_abnormal_thymus_physiology | 1.40180159 |
| 67 | MP0005623_abnormal_meninges_morphology | 1.39848328 |
| 68 | MP0002272_abnormal_nervous_system | 1.39159433 |
| 69 | MP0009333_abnormal_splenocyte_physiolog | 1.34401132 |
| 70 | MP0000465_gastrointestinal_hemorrhage | 1.32302090 |
| 71 | MP0004811_abnormal_neuron_physiology | 1.31996830 |
| 72 | MP0003879_abnormal_hair_cell | 1.31324018 |
| 73 | MP0006054_spinal_hemorrhage | 1.30962592 |
| 74 | MP0004130_abnormal_muscle_cell | 1.29067823 |
| 75 | MP0002837_dystrophic_cardiac_calcinosis | 1.28560961 |
| 76 | MP0002254_reproductive_system_inflammat | 1.28221097 |
| 77 | MP0002734_abnormal_mechanical_nocicepti | 1.26643315 |
| 78 | MP0004381_abnormal_hair_follicle | 1.26324859 |
| 79 | MP0009840_abnormal_foam_cell | 1.24170217 |
| 80 | MP0005310_abnormal_salivary_gland | 1.23394856 |
| 81 | MP0001970_abnormal_pain_threshold | 1.22085510 |
| 82 | MP0003866_abnormal_defecation | 1.20912080 |
| 83 | MP0003300_gastrointestinal_ulcer | 1.20623779 |
| 84 | MP0002722_abnormal_immune_system | 1.19280388 |
| 85 | MP0000689_abnormal_spleen_morphology | 1.18963686 |
| 86 | MP0004883_abnormal_blood_vessel | 1.18265615 |
| 87 | * MP0002429_abnormal_blood_cell | 1.16768817 |
| 88 | MP0000343_altered_response_to | 1.16260761 |
| 89 | MP0005397_hematopoietic_system_phenotyp | 1.14321815 |
| 90 | MP0001545_abnormal_hematopoietic_system | 1.14321815 |
| 91 | MP0003329_amyloid_beta_deposits | 1.14067959 |
| 92 | MP0003633_abnormal_nervous_system | 1.12469038 |
| 93 | MP0002277_abnormal_respiratory_mucosa | 1.10721950 |
| 94 | MP0003045_fibrosis | 1.09710776 |
| 95 | MP0003279_aneurysm | 1.09403660 |
| 96 | MP0003656_abnormal_erythrocyte_physiolo | 1.08892988 |
| 97 | MP0002396_abnormal_hematopoietic_system | 1.08561935 |
| 98 | MP0002184_abnormal_innervation | 1.08461361 |
| 99 | MP0002067_abnormal_sensory_capabilities | 1.07362273 |
| 100 | MP0003448_altered_tumor_morphology | 1.04804767 |
| 101 | MP0006138_congestive_heart_failure | 1.03059366 |
| 102 | MP0009278_abnormal_bone_marrow | 1.02653728 |
| 103 | MP0009046_muscle_twitch | 1.00740697 |
| 104 | MP0005076_abnormal_cell_differentiation | 1.00644589 |
| 105 | MP0003453_abnormal_keratinocyte_physiol | 0.99760304 |
| 106 | MP0008004_abnormal_stomach_pH | 0.99706807 |
| 107 | MP0003385_abnormal_body_wall | 0.98509511 |
| 108 | MP0003091_abnormal_cell_migration | 0.95311286 |
| 109 | MP0004215_abnormal_myocardial_fiber | 0.94283925 |
| 110 | MP0004085_abnormal_heartbeat | 0.93670504 |
| 111 | MP0002332_abnormal_exercise_endurance | 0.93646860 |
| 112 | MP0000703_abnormal_thymus_morphology | 0.92467916 |
| 113 | MP0000955_abnormal_spinal_cord | 0.92152304 |
| 114 | MP0000685_abnormal_immune_system | 0.92064098 |
| 115 | MP0000569_abnormal_digit_pigmentation | 0.91905730 |
| 116 | MP0000003_abnormal_adipose_tissue | 0.91784438 |
| 117 | MP0005670_abnormal_white_adipose | 0.89184529 |
| 118 | MP0005386_behavior/neurological_phenoty | 0.88979364 |
| 119 | MP0004924_abnormal_behavior | 0.88979364 |
| 120 | MP0001440_abnormal_grooming_behavior | 0.88674339 |
| 121 | MP0005390_skeleton_phenotype | 0.88103660 |
| 122 | MP0002166_altered_tumor_susceptibility | 0.87439650 |
| 123 | MP0005595_abnormal_vascular_smooth | 0.86739879 |
| 124 | MP0000534_abnormal_ureter_morphology | 0.83112279 |
| 125 | MP0000249_abnormal_blood_vessel | 0.82506125 |
| 126 | MP0001915_intracranial_hemorrhage | 0.81468597 |
| 127 | MP0005375_adipose_tissue_phenotype | 0.81357845 |
| 128 | MP0000920_abnormal_myelination | 0.80824714 |
| 129 | MP0004484_altered_response_of | 0.80471689 |
| 130 | MP0002933_joint_inflammation | 0.80333859 |
| 131 | MP0000767_abnormal_smooth_muscle | 0.80330978 |
| 132 | MP0009763_increased_sensitivity_to | 0.79075008 |
| 133 | MP0003221_abnormal_cardiomyocyte_apopto | 0.78696683 |
| 134 | MP0003705_abnormal_hypodermis_morpholog | 0.77683618 |
| 135 | MP0000778_abnormal_nervous_system | 0.76230654 |
| 136 | MP0005164_abnormal_response_to | 0.76055647 |
| 137 | MP0000751_myopathy | 0.75657232 |
| 138 | MP0003122_maternal_imprinting | 0.74464169 |
| 139 | MP0002928_abnormal_bile_duct | 0.72375356 |
| 140 | MP0003566_abnormal_cell_adhesion | 0.71997616 |
| 141 | MP0004264_abnormal_extraembryonic_tissu | 0.71796583 |
| 142 | MP0004808_abnormal_hematopoietic_stem | 0.71390654 |
| 143 | MP0005535_abnormal_body_temperature | 0.71227810 |
| 144 | MP0001790_abnormal_immune_system | 0.70747550 |
| 145 | MP0005387_immune_system_phenotype | 0.70747550 |
| 146 | MP0003787_abnormal_imprinting | 0.70422545 |
| 147 | MP0003795_abnormal_bone_structure | 0.69403731 |
| 148 | MP0002557_abnormal_social/conspecific_i | 0.69106578 |
| 149 | MP0004185_abnormal_adipocyte_glucose | 0.68892600 |
| 150 | MP0001853_heart_inflammation | 0.68450391 |
| 151 | MP0005023_abnormal_wound_healing | 0.67621448 |
| 152 | MP0002138_abnormal_hepatobiliary_system | 0.67141725 |
| 153 | MP0003724_increased_susceptibility_to | 0.66845525 |
| 154 | MP0001663_abnormal_digestive_system | 0.64958589 |
| 155 | MP0003631_nervous_system_phenotype | 0.64499997 |
| 156 | MP0010329_abnormal_lipoprotein_level | 0.64183062 |
| 157 | MP0005666_abnormal_adipose_tissue | 0.63836155 |
| 158 | MP0001851_eye_inflammation | 0.63343807 |
| 159 | MP0001800_abnormal_humoral_immune | 0.63302096 |
| 160 | MP0005187_abnormal_penis_morphology | 0.63249435 |
| 161 | MP0002925_abnormal_cardiovascular_devel | 0.62512098 |
| 162 | MP0002066_abnormal_motor_capabilities/c | 0.62493350 |
| 163 | MP0001835_abnormal_antigen_presentation | 0.62395606 |
| 164 | MP0005166_decreased_susceptibility_to | 0.61708375 |
| 165 | MP0000604_amyloidosis | 0.61332360 |
| 166 | MP0000609_abnormal_liver_physiology | 0.59661257 |
| 167 | MP0002006_tumorigenesis | 0.55011704 |
| 168 | MP0001958_emphysema | 0.54514313 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.04380493 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.53305991 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.46036193 |
| 4 | Orchitis (HP:0100796) | 5.29429676 |
| 5 | Abnormality of macrophages (HP:0004311) | 5.21631434 |
| 6 | Myositis (HP:0100614) | 5.19349326 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.99849047 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 4.96167066 |
| 9 | Optic neuritis (HP:0100653) | 4.96167066 |
| 10 | Focal motor seizures (HP:0011153) | 4.40097870 |
| 11 | Myokymia (HP:0002411) | 4.26600572 |
| 12 | Gastrointestinal infarctions (HP:0005244) | 3.86237002 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 3.73894727 |
| 14 | Focal seizures (HP:0007359) | 3.61345801 |
| 15 | Stomatitis (HP:0010280) | 3.59808598 |
| 16 | Keratoconjunctivitis sicca (HP:0001097) | 3.59170097 |
| 17 | Hemiplegia (HP:0002301) | 3.51326214 |
| 18 | Recurrent skin infections (HP:0001581) | 3.49589727 |
| 19 | Gingivitis (HP:0000230) | 3.47559025 |
| 20 | Recurrent fungal infections (HP:0002841) | 3.39707251 |
| 21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.33407624 |
| 22 | Obstructive lung disease (HP:0006536) | 3.30835601 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 3.30835601 |
| 24 | Meningitis (HP:0001287) | 3.26041446 |
| 25 | Abnormality of glycolipid metabolism (HP:0010969) | 3.24295751 |
| 26 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.24295751 |
| 27 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.24295751 |
| 28 | Keratoconjunctivitis (HP:0001096) | 3.24277125 |
| 29 | Peritonitis (HP:0002586) | 3.10913595 |
| 30 | Amyloidosis (HP:0011034) | 3.09984111 |
| 31 | Gingival bleeding (HP:0000225) | 3.09430872 |
| 32 | Vasculitis (HP:0002633) | 3.03419282 |
| 33 | Urticaria (HP:0001025) | 3.01972984 |
| 34 | Cerebral aneurysm (HP:0004944) | 2.98097493 |
| 35 | Asymmetry of the thorax (HP:0001555) | 2.93595063 |
| 36 | Annular pancreas (HP:0001734) | 2.92514303 |
| 37 | Agammaglobulinemia (HP:0004432) | 2.90206298 |
| 38 | Amblyopia (HP:0000646) | 2.84545889 |
| 39 | Encephalitis (HP:0002383) | 2.80381946 |
| 40 | Arterial thrombosis (HP:0004420) | 2.79622827 |
| 41 | Visual hallucinations (HP:0002367) | 2.79167815 |
| 42 | Prolonged bleeding time (HP:0003010) | 2.75779433 |
| 43 | Verrucae (HP:0200043) | 2.75744887 |
| 44 | Papilloma (HP:0012740) | 2.75744887 |
| 45 | Episodic fever (HP:0001954) | 2.75602704 |
| 46 | Increased cerebral lipofuscin (HP:0011813) | 2.73123657 |
| 47 | Papilledema (HP:0001085) | 2.69293170 |
| 48 | Pulmonary infiltrates (HP:0002113) | 2.69273744 |
| 49 | Atonic seizures (HP:0010819) | 2.67860095 |
| 50 | Hemoptysis (HP:0002105) | 2.66771491 |
| 51 | Recurrent cutaneous fungal infections (HP:0011370) | 2.65624402 |
| 52 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.65624402 |
| 53 | Chest pain (HP:0100749) | 2.65358484 |
| 54 | Hyperventilation (HP:0002883) | 2.65011508 |
| 55 | T lymphocytopenia (HP:0005403) | 2.64800064 |
| 56 | Systemic lupus erythematosus (HP:0002725) | 2.63987423 |
| 57 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.63855542 |
| 58 | Ankyloglossia (HP:0010296) | 2.62055063 |
| 59 | Pulmonary embolism (HP:0002204) | 2.58736931 |
| 60 | Hematochezia (HP:0002573) | 2.57359357 |
| 61 | Febrile seizures (HP:0002373) | 2.55947477 |
| 62 | Poor eye contact (HP:0000817) | 2.55571742 |
| 63 | Epistaxis (HP:0000421) | 2.54480494 |
| 64 | Loss of speech (HP:0002371) | 2.54057631 |
| 65 | Vertebral arch anomaly (HP:0008438) | 2.53686159 |
| 66 | Polygenic inheritance (HP:0010982) | 2.52899742 |
| 67 | Cellulitis (HP:0100658) | 2.52812538 |
| 68 | Broad metatarsal (HP:0001783) | 2.48933478 |
| 69 | Abnormality of T cell number (HP:0011839) | 2.48667557 |
| 70 | Action tremor (HP:0002345) | 2.47075383 |
| 71 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.46374014 |
| 72 | Purpura (HP:0000979) | 2.46320122 |
| 73 | Torticollis (HP:0000473) | 2.44655778 |
| 74 | Pointed chin (HP:0000307) | 2.43952185 |
| 75 | Subacute progressive viral hepatitis (HP:0006572) | 2.43150640 |
| 76 | Abnormality of the peritoneum (HP:0002585) | 2.41333941 |
| 77 | Lymphangioma (HP:0100764) | 2.37851467 |
| 78 | Impaired social interactions (HP:0000735) | 2.37681972 |
| 79 | Abnormal social behavior (HP:0012433) | 2.37681972 |
| 80 | Anorexia (HP:0002039) | 2.36714754 |
| 81 | Hypochromic microcytic anemia (HP:0004840) | 2.35110095 |
| 82 | Gangrene (HP:0100758) | 2.34331634 |
| 83 | Hypochromic anemia (HP:0001931) | 2.31148992 |
| 84 | Exotropia (HP:0000577) | 2.27685651 |
| 85 | Recurrent viral infections (HP:0004429) | 2.27177614 |
| 86 | Leukocytosis (HP:0001974) | 2.26206143 |
| 87 | Abnormality of the lower motor neuron (HP:0002366) | 2.26162711 |
| 88 | Dysostosis multiplex (HP:0000943) | 2.26000015 |
| 89 | Broad-based gait (HP:0002136) | 2.25048594 |
| 90 | Polycythemia (HP:0001901) | 2.24393185 |
| 91 | Osteomyelitis (HP:0002754) | 2.24082359 |
| 92 | Inflammation of the large intestine (HP:0002037) | 2.22257599 |
| 93 | Colitis (HP:0002583) | 2.21269295 |
| 94 | Myocardial infarction (HP:0001658) | 2.21059821 |
| 95 | Short 4th metacarpal (HP:0010044) | 2.19794480 |
| 96 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.19794480 |
| 97 | Mitral stenosis (HP:0001718) | 2.19463819 |
| 98 | Glomerulonephritis (HP:0000099) | 2.19389013 |
| 99 | Gastrointestinal inflammation (HP:0004386) | 2.16537538 |
| 100 | Abnormality of oral frenula (HP:0000190) | 2.15479001 |
| 101 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.12761707 |
| 102 | Glomerulopathy (HP:0100820) | 2.12064816 |
| 103 | Absence seizures (HP:0002121) | 2.11722266 |
| 104 | Resting tremor (HP:0002322) | 2.11228432 |
| 105 | Buphthalmos (HP:0000557) | 2.11219538 |
| 106 | Abnormality of the pleura (HP:0002103) | 2.11218322 |
| 107 | Hydroureter (HP:0000072) | 2.09172334 |
| 108 | Epileptic encephalopathy (HP:0200134) | 2.08949364 |
| 109 | Pustule (HP:0200039) | 2.08870723 |
| 110 | Stereotypic behavior (HP:0000733) | 2.07994251 |
| 111 | Abnormality of pain sensation (HP:0010832) | 2.07746784 |
| 112 | Impaired pain sensation (HP:0007328) | 2.07746784 |
| 113 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.07163477 |
| 114 | Postural instability (HP:0002172) | 2.06040719 |
| 115 | Depression (HP:0000716) | 2.05888986 |
| 116 | Abnormality of the endocardium (HP:0004306) | 2.03760987 |
| 117 | Arterial tortuosity (HP:0005116) | 2.03660593 |
| 118 | Slow saccadic eye movements (HP:0000514) | 2.02939589 |
| 119 | Lower limb amyotrophy (HP:0007210) | 2.01988112 |
| 120 | Diplopia (HP:0000651) | 2.00436930 |
| 121 | Abnormality of binocular vision (HP:0011514) | 2.00436930 |
| 122 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.99637740 |
| 123 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.99637740 |
| 124 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.99637740 |
| 125 | Increased serum ferritin (HP:0003281) | 1.99090042 |
| 126 | Truncal ataxia (HP:0002078) | 1.99072999 |
| 127 | Generalized tonic-clonic seizures (HP:0002069) | 1.98717269 |
| 128 | Sepsis (HP:0100806) | 1.98692214 |
| 129 | Viral hepatitis (HP:0006562) | 1.98062780 |
| 130 | Disinhibition (HP:0000734) | 1.97430899 |
| 131 | Increased variability in muscle fiber diameter (HP:0003557) | 1.97320205 |
| 132 | Interstitial pulmonary disease (HP:0006530) | 1.96708136 |
| 133 | Mucopolysacchariduria (HP:0008155) | 1.96566608 |
| 134 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.96566608 |
| 135 | Focal dystonia (HP:0004373) | 1.95344152 |
| 136 | Dysmetric saccades (HP:0000641) | 1.94529268 |
| 137 | Joint hemorrhage (HP:0005261) | 1.93603827 |
| 138 | Palpebral edema (HP:0100540) | 1.93192784 |
| 139 | Overgrowth (HP:0001548) | 1.93065718 |
| 140 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.92838848 |
| 141 | Mitral valve prolapse (HP:0001634) | 1.92187683 |
| 142 | Craniofacial dystonia (HP:0012179) | 1.91256411 |
| 143 | Arthropathy (HP:0003040) | 1.90783929 |
| 144 | Vertigo (HP:0002321) | 1.89736596 |
| 145 | Hypoplasia of the iris (HP:0007676) | 1.89509387 |
| 146 | Follicular hyperkeratosis (HP:0007502) | 1.88596202 |
| 147 | Hemiparesis (HP:0001269) | 1.86948562 |
| 148 | Hypoventilation (HP:0002791) | 1.86504937 |
| 149 | Aqueductal stenosis (HP:0002410) | 1.86465932 |
| 150 | Spontaneous hematomas (HP:0007420) | 1.86368198 |
| 151 | Obstructive sleep apnea (HP:0002870) | 1.86320357 |
| 152 | Increased IgM level (HP:0003496) | 1.86209976 |
| 153 | Acne (HP:0001061) | 1.84456137 |
| 154 | Granulocytopenia (HP:0001913) | 1.84399611 |
| 155 | Vacuolated lymphocytes (HP:0001922) | 1.84214486 |
| 156 | Deep venous thrombosis (HP:0002625) | 1.83146802 |
| 157 | Anxiety (HP:0000739) | 1.82465723 |
| 158 | Abnormal platelet volume (HP:0011876) | 1.82286436 |
| 159 | Skin ulcer (HP:0200042) | 1.82267551 |
| 160 | Thrombophlebitis (HP:0004418) | 1.82097356 |
| 161 | Menorrhagia (HP:0000132) | 1.82096084 |
| 162 | Lower limb asymmetry (HP:0100559) | 1.81466470 |
| 163 | Abnormality of the pericardium (HP:0001697) | 1.80678991 |
| 164 | Neurofibrillary tangles (HP:0002185) | 1.80570770 |
| 165 | Vascular tortuosity (HP:0004948) | 1.79977898 |
| 166 | Aortic aneurysm (HP:0004942) | 1.79036428 |
| 167 | Pathologic fracture (HP:0002756) | 1.78696061 |
| 168 | Long eyelashes (HP:0000527) | 1.78510215 |
| 169 | Supranuclear gaze palsy (HP:0000605) | 1.78230650 |
| 170 | Abnormality of T cells (HP:0002843) | 1.78207031 |
| 171 | Hepatosplenomegaly (HP:0001433) | 1.77864801 |
| 172 | Dialeptic seizures (HP:0011146) | 1.76984486 |
| 173 | Striae distensae (HP:0001065) | 1.74520964 |
| 174 | Absent frontal sinuses (HP:0002688) | 1.73460147 |
| 175 | Scanning speech (HP:0002168) | 1.73438925 |
| 176 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.71362801 |
| 177 | Progressive cerebellar ataxia (HP:0002073) | 1.70952472 |
| 178 | Deep palmar crease (HP:0006191) | 1.70700222 |
| 179 | Aneurysm (HP:0002617) | 1.67379554 |
| 180 | Prominent supraorbital ridges (HP:0000336) | 1.66513929 |
| 181 | Visceral angiomatosis (HP:0100761) | 1.65046918 |
| 182 | Increased IgE level (HP:0003212) | 1.64657695 |
| 183 | Macroorchidism (HP:0000053) | 1.64558187 |
| 184 | Abnormality of the 4th metacarpal (HP:0010012) | 1.64383214 |
| 185 | Shallow orbits (HP:0000586) | 1.64004399 |
| 186 | Narrow palate (HP:0000189) | 1.63844293 |
| 187 | Dilatation of the ascending aorta (HP:0005111) | 1.62460642 |
| 188 | Stroke (HP:0001297) | 1.62442391 |
| 189 | Distal lower limb amyotrophy (HP:0008944) | 1.60332384 |
| 190 | Asymmetric growth (HP:0100555) | 1.59104420 |
| 191 | Urinary urgency (HP:0000012) | 1.58763036 |
| 192 | Trigonocephaly (HP:0000243) | 1.58723595 |
| 193 | Obsessive-compulsive behavior (HP:0000722) | 1.58450969 |
| 194 | Limited hip movement (HP:0008800) | 1.56558964 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.25695517 |
| 2 | RIPK4 | 4.06340155 |
| 3 | BLK | 3.27987162 |
| 4 | NTRK3 | 3.22340276 |
| 5 | MAP3K9 | 3.02415557 |
| 6 | MAP2K3 | 2.97324952 |
| 7 | IRAK4 | 2.96058082 |
| 8 | TIE1 | 2.81644670 |
| 9 | CSK | 2.67324512 |
| 10 | KDR | 2.55754586 |
| 11 | KSR2 | 2.50026115 |
| 12 | CAMK1G | 2.42070071 |
| 13 | PRPF4B | 2.29347225 |
| 14 | MAP3K3 | 2.15377053 |
| 15 | DAPK2 | 1.98738401 |
| 16 | SIK2 | 1.95033930 |
| 17 | ZAP70 | 1.93648041 |
| 18 | PTK2B | 1.84619837 |
| 19 | TRIB3 | 1.81727519 |
| 20 | MAP3K14 | 1.81130809 |
| 21 | MAP3K13 | 1.71783504 |
| 22 | RIPK1 | 1.67665717 |
| 23 | FES | 1.63273093 |
| 24 | MAP3K10 | 1.61285820 |
| 25 | MINK1 | 1.54836019 |
| 26 | MAP3K11 | 1.53903984 |
| 27 | KSR1 | 1.51847897 |
| 28 | JAK3 | 1.51534722 |
| 29 | GRK6 | 1.48889831 |
| 30 | TNK2 | 1.45656690 |
| 31 | IKBKE | 1.43592228 |
| 32 | NTRK1 | 1.38095003 |
| 33 | IRAK3 | 1.37491561 |
| 34 | TBK1 | 1.36770312 |
| 35 | PNCK | 1.33390973 |
| 36 | CAMK1D | 1.30252899 |
| 37 | YES1 | 1.26099470 |
| 38 | TGFBR2 | 1.25971624 |
| 39 | CAMKK1 | 1.22105947 |
| 40 | BTK | 1.21492369 |
| 41 | MARK2 | 1.20349483 |
| 42 | MAP2K4 | 1.16620705 |
| 43 | MAP3K2 | 1.16314580 |
| 44 | EPHB2 | 1.16137361 |
| 45 | MAP2K1 | 1.14621517 |
| 46 | IRAK2 | 1.11741315 |
| 47 | MAP3K4 | 1.10942927 |
| 48 | TAOK1 | 1.10033593 |
| 49 | LYN | 1.09176567 |
| 50 | TAOK2 | 1.08954117 |
| 51 | EPHA3 | 1.07755701 |
| 52 | RET | 1.06011393 |
| 53 | MAP3K6 | 1.05378627 |
| 54 | IRAK1 | 1.05176006 |
| 55 | DAPK1 | 1.02426322 |
| 56 | BMPR2 | 1.00433446 |
| 57 | TXK | 1.00083745 |
| 58 | CAMK1 | 0.97095244 |
| 59 | PAK6 | 0.97008299 |
| 60 | FGFR3 | 0.96835762 |
| 61 | PKN2 | 0.96403556 |
| 62 | MAP3K7 | 0.94768657 |
| 63 | CDK5 | 0.94680004 |
| 64 | PRKD3 | 0.94495775 |
| 65 | LRRK2 | 0.93706271 |
| 66 | PDGFRA | 0.93681601 |
| 67 | MAP4K1 | 0.92320204 |
| 68 | MAP3K12 | 0.92209916 |
| 69 | DMPK | 0.90130471 |
| 70 | PRKCH | 0.89797404 |
| 71 | LCK | 0.88908050 |
| 72 | PTK6 | 0.88368317 |
| 73 | STK10 | 0.88027812 |
| 74 | TAOK3 | 0.87737613 |
| 75 | SMG1 | 0.87082508 |
| 76 | JAK1 | 0.86817860 |
| 77 | MAP3K1 | 0.84496145 |
| 78 | RAF1 | 0.82720790 |
| 79 | CAMK4 | 0.82205992 |
| 80 | SIK1 | 0.81735782 |
| 81 | SGK3 | 0.81444212 |
| 82 | GRK5 | 0.80312157 |
| 83 | STK11 | 0.80210312 |
| 84 | ICK | 0.75821278 |
| 85 | ERN1 | 0.74799175 |
| 86 | SYK | 0.74226198 |
| 87 | MARK1 | 0.72007139 |
| 88 | IKBKB | 0.70970555 |
| 89 | MAP3K5 | 0.69292682 |
| 90 | PDK1 | 0.68916876 |
| 91 | MATK | 0.68528781 |
| 92 | ALK | 0.67567683 |
| 93 | NTRK2 | 0.66938696 |
| 94 | HCK | 0.65413428 |
| 95 | PDPK1 | 0.64789364 |
| 96 | SIK3 | 0.64756076 |
| 97 | SGK2 | 0.63339158 |
| 98 | MAP2K7 | 0.62928299 |
| 99 | STK38 | 0.62817696 |
| 100 | MAPK12 | 0.62153962 |
| 101 | DYRK1B | 0.61717713 |
| 102 | GRK7 | 0.61678638 |
| 103 | ITK | 0.60167313 |
| 104 | FGFR4 | 0.59748792 |
| 105 | MAPK13 | 0.59403409 |
| 106 | MOS | 0.58152053 |
| 107 | FYN | 0.57012347 |
| 108 | SGK1 | 0.55067104 |
| 109 | PIK3CG | 0.54534960 |
| 110 | FGFR2 | 0.52507642 |
| 111 | TESK2 | 0.52372388 |
| 112 | ARAF | 0.52287024 |
| 113 | MAPK7 | 0.52257956 |
| 114 | PRKCG | 0.51169806 |
| 115 | WNK1 | 0.50914275 |
| 116 | FGR | 0.49060542 |
| 117 | MARK3 | 0.48995246 |
| 118 | PLK2 | 0.48626088 |
| 119 | PAK3 | 0.47900767 |
| 120 | FER | 0.46874300 |
| 121 | HIPK2 | 0.46646898 |
| 122 | RPS6KA2 | 0.46628184 |
| 123 | TGFBR1 | 0.46115215 |
| 124 | CDK12 | 0.46027086 |
| 125 | PRKD2 | 0.44824680 |
| 126 | PTK2 | 0.43925495 |
| 127 | MAPKAPK2 | 0.43792028 |
| 128 | CDC42BPA | 0.43569946 |
| 129 | PDGFRB | 0.43427007 |
| 130 | PAK4 | 0.43304943 |
| 131 | TYK2 | 0.42638162 |
| 132 | JAK2 | 0.42269608 |
| 133 | PRKD1 | 0.42223204 |
| 134 | PRKCZ | 0.41937350 |
| 135 | EPHB1 | 0.41800451 |
| 136 | SRC | 0.40684926 |
| 137 | MAPK4 | 0.40439371 |
| 138 | RPS6KL1 | 0.39535686 |
| 139 | RPS6KC1 | 0.39535686 |
| 140 | NLK | 0.38801271 |
| 141 | SGK494 | 0.36544335 |
| 142 | SGK223 | 0.36544335 |
| 143 | MAP2K6 | 0.35954666 |
| 144 | CSF1R | 0.35567431 |
| 145 | KIT | 0.35455442 |
| 146 | PRKAA2 | 0.35185401 |
| 147 | TTN | 0.32930290 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.90267320 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.76722866 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.21958292 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.12543851 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.05582360 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 1.98805671 |
| 7 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.98059910 |
| 8 | Malaria_Homo sapiens_hsa05144 | 1.91765968 |
| 9 | Salivary secretion_Homo sapiens_hsa04970 | 1.91401335 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 1.77599596 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 1.74752461 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.74406401 |
| 13 | Nicotine addiction_Homo sapiens_hsa05033 | 1.74378247 |
| 14 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.73658811 |
| 15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.72674829 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.71974110 |
| 17 | Renin secretion_Homo sapiens_hsa04924 | 1.70912138 |
| 18 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.63275649 |
| 19 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.62875426 |
| 20 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.61839794 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.61744544 |
| 22 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.61714021 |
| 23 | Legionellosis_Homo sapiens_hsa05134 | 1.61245670 |
| 24 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.59074174 |
| 25 | Allograft rejection_Homo sapiens_hsa05330 | 1.56612406 |
| 26 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.56511059 |
| 27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.56116255 |
| 28 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.55873520 |
| 29 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.54370917 |
| 30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.51918416 |
| 31 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.51093638 |
| 32 | Measles_Homo sapiens_hsa05162 | 1.49639689 |
| 33 | GABAergic synapse_Homo sapiens_hsa04727 | 1.48545311 |
| 34 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.48284887 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.44114199 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 1.42696212 |
| 37 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.41849531 |
| 38 | Phagosome_Homo sapiens_hsa04145 | 1.40130904 |
| 39 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.39479176 |
| 40 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.39115733 |
| 41 | Pertussis_Homo sapiens_hsa05133 | 1.37008383 |
| 42 | Glioma_Homo sapiens_hsa05214 | 1.36910919 |
| 43 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.36886024 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.30809952 |
| 45 | Long-term depression_Homo sapiens_hsa04730 | 1.30773107 |
| 46 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.30764478 |
| 47 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.29676415 |
| 48 | Lysosome_Homo sapiens_hsa04142 | 1.29210702 |
| 49 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.29145453 |
| 50 | Gap junction_Homo sapiens_hsa04540 | 1.27121557 |
| 51 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.24054375 |
| 52 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.23517385 |
| 53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.21827063 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 1.19551489 |
| 55 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.19116413 |
| 56 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.18085565 |
| 57 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.17885665 |
| 58 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.17295965 |
| 59 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.16955197 |
| 60 | Hepatitis B_Homo sapiens_hsa05161 | 1.16927313 |
| 61 | Cocaine addiction_Homo sapiens_hsa05030 | 1.16162939 |
| 62 | Melanogenesis_Homo sapiens_hsa04916 | 1.15395627 |
| 63 | Insulin secretion_Homo sapiens_hsa04911 | 1.15370360 |
| 64 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.14507360 |
| 65 | Salmonella infection_Homo sapiens_hsa05132 | 1.14423582 |
| 66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.13626374 |
| 67 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.11401522 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.11110980 |
| 69 | Viral myocarditis_Homo sapiens_hsa05416 | 1.10576420 |
| 70 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.10197317 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.08260989 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.07926766 |
| 73 | Axon guidance_Homo sapiens_hsa04360 | 1.06617555 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.06230847 |
| 75 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.05858831 |
| 76 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.04460551 |
| 77 | Taste transduction_Homo sapiens_hsa04742 | 1.03482585 |
| 78 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.03407787 |
| 79 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.03292943 |
| 80 | Platelet activation_Homo sapiens_hsa04611 | 0.99859856 |
| 81 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.99779871 |
| 82 | Apoptosis_Homo sapiens_hsa04210 | 0.97936830 |
| 83 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.96952890 |
| 84 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.96828703 |
| 85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.96485339 |
| 86 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.95564568 |
| 87 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.95365197 |
| 88 | Shigellosis_Homo sapiens_hsa05131 | 0.92675886 |
| 89 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.91855354 |
| 90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.91090482 |
| 91 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.91076361 |
| 92 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90522650 |
| 93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89553847 |
| 94 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85129285 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | 0.83892513 |
| 96 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83448892 |
| 97 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.82166098 |
| 98 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.81608170 |
| 99 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.81121818 |
| 100 | Focal adhesion_Homo sapiens_hsa04510 | 0.81046221 |
| 101 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.81014536 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80798327 |
| 103 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.79127004 |
| 104 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.79092196 |
| 105 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.78216855 |
| 106 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.78007821 |
| 107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.76891483 |
| 108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.76406147 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76053213 |
| 110 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.71329263 |
| 111 | Bile secretion_Homo sapiens_hsa04976 | 0.71288946 |
| 112 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.70746614 |
| 113 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.70356946 |
| 114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.69937359 |
| 115 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.69595078 |
| 116 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.69384792 |
| 117 | Insulin resistance_Homo sapiens_hsa04931 | 0.68525603 |
| 118 | Adherens junction_Homo sapiens_hsa04520 | 0.67475614 |
| 119 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.66076776 |
| 120 | Asthma_Homo sapiens_hsa05310 | 0.65860000 |
| 121 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65801047 |
| 122 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64726468 |
| 123 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.63600090 |
| 124 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.61963817 |
| 125 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61609315 |
| 126 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.61369217 |
| 127 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60170818 |
| 128 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.60134506 |
| 129 | Endometrial cancer_Homo sapiens_hsa05213 | 0.60032393 |
| 130 | * Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.59830591 |
| 131 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59275949 |
| 132 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.58282679 |
| 133 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.57290528 |
| 134 | Bladder cancer_Homo sapiens_hsa05219 | 0.56529999 |
| 135 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.55171744 |
| 136 | Prion diseases_Homo sapiens_hsa05020 | 0.54817647 |
| 137 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53528679 |
| 138 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.52460448 |
| 139 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.52235833 |
| 140 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.52014538 |
| 141 | Colorectal cancer_Homo sapiens_hsa05210 | 0.51155811 |
| 142 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50867385 |
| 143 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.50526442 |
| 144 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.50223636 |
| 145 | Prostate cancer_Homo sapiens_hsa05215 | 0.49681456 |
| 146 | Endocytosis_Homo sapiens_hsa04144 | 0.48934787 |
| 147 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47714478 |
| 148 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46643396 |
| 149 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.46381066 |
| 150 | Pathways in cancer_Homo sapiens_hsa05200 | 0.46325389 |
| 151 | Tuberculosis_Homo sapiens_hsa05152 | 0.46065624 |
| 152 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.46000627 |
| 153 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45705607 |
| 154 | Thyroid cancer_Homo sapiens_hsa05216 | 0.45681118 |
| 155 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.44490356 |

